SKP2 and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, we have also experimentally demonstrated that both pharmacological and genetic inhibition of USP10 are capable of, in a SKP2-depednet manner, suppressing the proliferation of both IM-sensitive and IM-resistant CML cells in cell cultures and in mouse xenograft models.